Clinical Trial

An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease

Study acronym: ENCORE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-10-08; most recent amendment 2022-07-09.
Status change: Not Yet Recruiting → Recruiting 2022-06-16
Trial Details
NCT Number NCT05085171
Lead Sponsor Makerere University
Collaborators: University of Minnesota
Conditions The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease
Enrollment 2,400 participants
Start Date 2022-05-04
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2022-07-12